Doing What Matters in Times of Stress
📚 “Doing What Matters in Times of Stress: An Illustrated Guide” 🌟 🧑🔬🧑⚕️by World Health Organization. Stress is an inevitable part of life, and learning to navigate through challenging times is crucial for our well-being. That’s why we’re excited to…
Handling Missing Data Cheat Sheet
Missing data can be a common challenge in research studies, but fear not! Understanding the nature of missing data is essential for accurate analysis and robust conclusions. 🧩✨ Introducing the “Handling Missing Data Cheat Sheet”📝 by TUNECT CRO, a valuable resource that…
R function as a validation of graphical outputs to increase efficiency
Recently, a growing number of R packages are appearing for clinical trials. The implementation of all possible standards required for submission to the FDA, such as the creation of .XPT, the development of SDTM and ADAM, has long been in…
Alex Rosis about TUNECT
Coincidentally, Alex Rosis began working with us a few days prior to Christmas. It’s a pleasure to have you here this year. A strong business development department is one of the most significant components of the team. We proudly work…
electronic Clinical Outcome Assessment (eCOA)
🔹 Uniform terminology, serving as the fundamental language, holds paramount importance across various domains of human activities, and this truth extends to the rapidly evolving domain of electronic Clinical Outcome Assessment (eCOA). As a young direction, standardizing eCOA terminology is…
the independent data monitoring committee is planned is the IDMC Charter
The first document you should think about when the independent data monitoring committee is planned is the IDMC Charter, which is crucial for outlining the standard operating procedure of the committee. The Charter purpose is describing of processes during the…
FDA Approves first Gene Therapy to treat adults with Hemophilia B
Prior to the COVID-19 pandemic, much research was devoted to the study of gene therapy and, in particular, to adeno-associated virus vector gene therapy. The research was carried out in oncology, hemophilia, and other serious and/or orphan diseases, however, approved…
Neuralink chip
🚀The FDA has officially approved Elon Musk’s Neuralink chip to proceed with human trials, marking a momentous milestone in the field of neuroscience. 🔬This revolutionary brain-computer interface (BCI) technology, developed by Elon Musk’s Neuralink, has the potential to transform the treatment of neurological disorders…
Menu